Cindy Elko-Simms, M.D., serves as senior vice president of pharmacovigilance (PV) and regulatory affairs (RA) at PPD and is a member of the company’s global clinical development leadership team. Dr. Elko-Simms’ leadership and corporate risk management expertise help ensure regulatory compliance and the efficient execution of PV and RA services. She sets strategic vision and leadership for business process optimization and for technology road-map planning and contributes to assessments at an enterprise level. She supports strategic partnership relationships and serves as the chair of PPD’s executive medical risk review committee, which is responsible for addressing escalated potential patient safety issues.
Dr. Elko-Simms joined PPD in 2005 as an associate medical director. In the time since, she has held successive leadership roles within PV, including lead medical director, executive medical director, global executive medical director, vice president and senior vice president. In 2018, her leadership scope expanded to include RA services. Dr. Elko-Simms has participated in the conduct of clinical trials in multiple therapeutic areas, as well as provided drug safety monitoring. Her areas of expertise include HIV, hepatitis B, hepatitis C and general infectious diseases.
Dr. Elko-Simms completed a residency in internal medicine and a fellowship in infectious diseases at the University of South Florida. She is a cum laude graduate of Saint Louis University School of Medicine, where she was elected to the Alpha Omega Alpha honor society. Previously, she was elected to the Rho Chi honor society and graduated magna cum laude in pharmacy from Drake University.